Yves Kremer

Yves Kremer has extensive experience in clinical research, data analysis, and brain imaging in various prestigious institutions. Currently, Yves holds a managerial position at AC Immune, focusing on investor communication, competitive intelligence, and scientific messaging in the neurodegeneration field. Prior to this role, Yves was a Clinical Scientist at GTX medical, where Yves conducted assessments on therapeutic benefits for spinal cord injury rehabilitation. Additionally, Yves has a background in deep brain recordings in Parkinson's disease patients and sensory perception research.